BBLG Earnings Bone Biologics Corp
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–19 of 19
| Q1 2026 | 2026-03-31 | -0.43 | 2026-05-14 | 10-Q |
| FY 2025 | 2025-12-31 | -2.65 | 2026-03-02 | 10-K |
| Q3 2025 | 2025-09-30 | -2.51 | 2025-11-14 | 10-Q |
| Q2 2025 | 2025-06-30 | -3.23 | 2025-08-14 | 10-Q |
| Q1 2026 | 2025-03-31 | -1.92 | 2026-05-14 | 10-Q |
| FY 2025 | 2024-12-31 | -28.96 | 2026-03-02 | 10-K |
| Q3 2025 | 2024-09-30 | -29.09 | 2025-11-14 | 10-Q |
| Q2 2025 | 2024-06-30 | -10.82 | 2025-08-14 | 10-Q |
| Q1 2025 | 2024-03-31 | -1.31 | 2025-05-12 | 10-Q |
| FY 2024 | 2023-12-31 | -34.01 | 2025-02-26 | 10-K |
| Q3 2024 | 2023-09-30 | -37.40 | 2024-11-14 | 10-Q |
| Q2 2024 | 2023-06-30 | -18.57 | 2024-08-09 | 10-Q |
| Q1 2024 | 2023-03-31 | -55.20 | 2024-05-14 | 10-Q |
| FY 2023 | 2022-12-31 | -31.15 | 2024-02-21 | 10-K |
| Q3 2023 | 2022-09-30 | -6.89 | 2023-11-14 | 10-Q |
| Q2 2023 | 2022-06-30 | -3.36 | 2023-08-14 | 10-Q |
| Q2 2018 | 2018-06-30 | -0.62 | 2018-08-14 | 10-Q |
| Q2 2018 | 2017-06-30 | -0.49 | 2018-08-14 | 10-Q |
| Q2 2017 | 2016-06-30 | -0.32 | 2017-08-08 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.